RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers

Author:

Aguilar Ruth1ORCID,Li Xue2,Crowell Claudia S.2,Burrell Teresa2,Vidal Marta1,Rubio Rocio1,Jiménez Alfons13,Hernández-Luis Pablo45,Hofmann Dieter67,Mijočević Hrvoje6,Jeske Samuel6,Christa Catharina6,D'Ippolito Elvira2,Lingor Paul8,Knolle Percy A.79,Roggendorf Hedwig9,Priller Alina9,Yazici Sarah9,Carolis Carlo10,Mayor Alfredo1,Schreiner Patrik11,Poppert Holger12,Beyer Henriette12,Schambeck Sophia E.212,Izquierdo Luis113ORCID,Tortajada Marta14,Angulo Ana45,Soutschek Erwin11,Engel Pablo45,Garcia-Basteiro Alberto11315,Busch Dirk H.27,Moncunill Gemma113ORCID,Protzer Ulrike67ORCID,Dobaño Carlota113ORCID,Gerhard Markus27ORCID

Affiliation:

1. ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain

2. Institute of Medical Microbiology, Immunology, and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany

3. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

4. Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain

5. Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

6. Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany

7. German Center for Infection Research (DZIF), Munich, Germany

8. Klinikum rechts der Isar, Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany

9. Klinikum rechts der Isar, Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich, Munich, Germany

10. Biomolecular Screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain

11. Mikrogen GmbH, Munich, Germany

12. Helios Klinikum München West, Munich, Germany

13. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain

14. Occupational Health Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

15. Department of Preventive Medicine and Epidemiology, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain

Abstract

Neutralizing antibody titers are the best correlate of protection against SARS-CoV-2. However, current tests to measure plasma or serum neutralizing activity do not allow high-throughput screening at the population level.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3